Jaume Pons

Company: ALX Oncology

Job title: Chief Scientific Officer

Seminars:

Considering the Rationale Behind Developing Combination Therapies to Maximize their Potential Effectiveness 1:30 pm

Strategizing the logical design of a combination therapy to enhance the efficacy of your macrophage-directed therapy Weighing up the benefits and drawbacks of combination therapies to grasp their appeal Reviewing the costs and other limiting factors associated with combination therapiesRead more

day: Conference Day One